Label-Free Profiling of up to 200 Single-Cell Proteomes per Day Using a Dual-Column Nanoflow Liquid Chromatography Platform
Kei G. I. Webber(Brigham Young University), Ryan Kelly(Brigham Young University), Gregory P. Nordin(Brigham Young University), Arianna C. Mahoney(Brigham Young University), Fletcher B. Smith(Brigham Young University), Andikan J. Nwosu(Brigham Young University), Richard H. Carson(Brigham Young University), Alexander D. Buttars(Brigham Young University), Sebastian E. Zapata(Brigham Young University), Jacob M. Davis(Brigham Young University), Hailey Jones(Brigham Young University), Thy Truong(Brigham Young University), S. Madisyn Johnston(Brigham Young University), Yiran Liang(Qilu Hospital of Shandong University), Ying Zhu(Pacific Northwest National Laboratory), Andrey Liyu(Pacific Northwest National Laboratory), Jacob L. Heninger(Brigham Young University)
Cited by 93
Related Papers
Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
|Seminars in Cancer Biology|2019|1k
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
|Molecular Therapy|2019|513
RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
|Molecular Cancer|2020|396
The emerging landscape of single-molecule protein sequencing technologies
|Nature Methods|2021|359
LncRNA–CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA‐215
|Journal of Cellular Physiology|2018|301